Merck & Co., Inc.,
Dificid - Fidaxomicin for Oral Suspension
DIFICID is a macrolidc antibacterial indicated in adult and pediatric patients 6 months of age and older for the treatment of C. difficile-as&ocizicA diarrhea. 0.1). To reduce the development of drug-resistant bacteria and maintain the effectiveness of DIFICID and other antibacterial drugs, DIFICID should be used only to treat infections that arc proven or strongly suspected to be caused by C.diffkile. 0-2).
Most popular related searches
abdominal pain
pediatry patient
drug resistance
drug resistant
diarrhea
pediatry
diarrhea vomiting
anemia
gastrointestinal
drug use
ADVERSE REACTIONS
- The mosl common adverse reactions in adulls (incidence >2%) are nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, and neutropenia. (6)
- The most common adverse reactions in pediatric patients (incidence >5%) treated with DM l( id arc pyrexia, abdominal pain, vomiting, diarrhea, constipation, increased aminotransferases, and rash. (6)